Thermo Fisher Scientific launches ‘Make in India’ Air Quality Monitoring Systems to support India’s clean air initiatives

▴ Thermo Fisher Scientific
Thermo Fisher offers the industry’s most comprehensive line of environment monitoring systems such as CAAQMS and CEMS for detecting a broad range of gaseous and aerosol pollutants.

Pune, 27th May 2024: Thermo Fisher Scientific, the world leader in serving science, has announced the commencement of manufacturing of Air Quality Monitoring System (AQMS) analyzers in India. The analyzers will be engineered, manufactured and validated at Thermo Fisher’s facility at Nasik, Maharashtra.

Thermo Fisher has been supporting leading players in cement, metals, mining, oil and gas, power, chemicals and other industries in India with these analyzers, manufactured at its facilities in the USA and China. The analyzers are then assembled into Make in India Class 1 Continuous Ambient Air Quality Monitoring Station (CAAQMS) at its Pune facility.

By now manufacturing these analyzers in India, Thermo Fisher has further fortified its commitment to India’s localization and environmental stewardship efforts.

Designed to provide accurate data on air pollutants and gases, the AQMS analyzers play a crucial role in monitoring and regulating industrial emissions, contributing to the government’s efforts in curbing air pollution.

Mr. Jatinder Singh Kamyotra, former Member Secretary and Director of Central Pollution Control Board, a key figure in India’s clean air initiatives, believes that the availability of these Make in India Class 1 CAAQMS will strengthen the monitoring network. Speaking at the launch he stated, “The localization will minimize downtime for the availability of these analyzers and enable stakeholders to provide better quality data to formulate policies to positively impact the environment.”

 

Mr. Nihar Sahoo, Ph. D., Chief Environmental Engineer, State Pollution Control Board and Head of the National Clean Air Programme, Odisha, further added, “The National Clean Air Programme aims at reducing air pollution by 20-40% with a focus on reduction of Pollutants PM10 and PM2.5. To ensure that we achieve these ambitious targets, there is a need for high-quality equipment that provides accurate and consistent baseline data on the particulate and gas pollutants. The programme was initiated in 2019 and since most of the systems, particularly for continuous air monitoring were imported, we faced many challenges in the operations and maintenance of these systems. The availability of Make in India Class 1 CAAQMS systems is likely to reduce the overall cost and turnaround time, thereby accelerating the effective implementation of the program.”

 

Thermo Fisher offers the industry’s most comprehensive line of environment monitoring systems such as CAAQMS and CEMS for detecting a broad range of gaseous and aerosol pollutants.

 

Miguel Faustino, President, Chemical Analysis, Thermo Fisher Scientific, highlighted the company’s commitment to India’s sustainable business environment, saying, “Thermo Fisher’s Mission to enable our customer to make the world healthier, cleaner and safer is aligned to India’s ambitious sustainability goals. The localization of our industry-leading innovations reflects our ongoing investments to address the complex environmental and process monitoring challenges in the country."

 

Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific, emphasized the significance of these efforts, stating, “Air pollution remains a major challenge in India, impacting the health and well-being of millions. By investing in localized capabilities, we strive to strengthen our partnership with government and regulatory stakeholders for action-oriented measures for a healthier, cleaner and safer India.”

 

Thermo Fisher’s monitoring solutions have been instrumental in helping manufacturing plants across industries such as food and beverage, oil and gas, petrochemicals, power generation, steel and metals, and mining, operate safely, efficiently and in compliance.


The company established operations in India in 1996, continually expanding its operations and reach across the country. With its headquarters in Mumbai, the company has an employee strength of over 4400 employees operating in 42 cities.  Through its extensive capabilities, including eight distribution centers, eight manufacturing facilities, five application labs and two R&D centers, supported by an extensive network of 400-plus channel partners, Thermo Fisher offers advanced technologies to meet the diverse needs of its customers in India.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026